AYTU BIOPHARMA, INC (AYTU) Operating margin 2016–2025
AYTU BIOPHARMA, INC (AYTU) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.8%FY2025 · since FY2016: -847.0% → -11.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.8% | -9.4 pp |
| FY2024 | -2.4% | +13.4 pp |
| FY2023 | -15.9% | +97.8 pp |
| FY2022 | -113.7% | -24.0 pp |
| FY2021 | -89.7% | -13.2 pp |
| FY2020 | -76.5% | +153.7 pp |
| FY2019 | -230.1% | +308.1 pp |
| FY2018 | -538.2% | +86.5 pp |
| FY2017 | -624.7% | +222.3 pp |
| FY2016 | -847.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice